Phenominer Database Results (69 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
Crl:SD serum aspartate aminotransferase activity level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood aspartate transaminase amount male 63 days 5 61.8 U/l 1.32 2.95 automated serum analysis 0.0 0 105049 3010
Crl:SD plasma albumin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood albumin amount male 91 days-154 days 0 25.8 g/l 0.4 automated plasma albumin analysis 0 plasma albumin level 106831 3067
Crl:SD plasma alkaline phosphatase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood alkaline phosphatase amount male 91 days-154 days 0 279.8 IU/l 45.35 automated plasma alkaline phosphatase activity assay 0 plasma AP 106875 3067
Crl:SD plasma triglyceride level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood triglyceride amount female 91 days-154 days 0 0.77 mmol/l 0.09 automated plasma triglyceride analysis 0 plasma triglyceride 106844 3067
Crl:SD plasma total cholesterol level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood cholesterol amount female 91 days-154 days 0 71.04 mg/dl 6.18 automated plasma total cholesterol analysis 0 plasma total cholesterol 106848 3067
Crl:SD plasma sodium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood sodium amount male 91 days-154 days 0 139.6 mmol/l 0.42 automated plasma sodium test 0 plasma sodium 106851 3067
Crl:SD plasma glucose level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood glucose amount male 91 days-154 days 0 180.0 mg/dl 7.56 automated plasma glucose analysis 0 plasma glucose 106859 3067
Crl:SD plasma gamma-glutamyltransferase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood gamma-glutamyltransferase amount female 91 days-154 days 0 0.0 U/l 0.0 automated plasma gamma-glutamyltransferase activity assay 0 automated plasma gamma-glutamyltransferase activity assay (MMO:0000831) plasma GGT activity 106864 3067
Crl:SD plasma total bilirubin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood bilirubin amount male 91 days-154 days 0 0.13 mg/dl 0.03 automated plasma total bilirubin analysis 0.0 0 automated plasma total bilirubin analysis (MMO:0000824) total plasma bilirubin 111466 3067
Crl:SD brain sitosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. brain sitosterol amount not specified 77 days 2 0.02 mg/g unspecified method 0.0 0 tissue lipid analysis 70541 1300
Crl:SD serum alkaline phosphatase activity level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood alkaline phosphatase amount male 63 days 5 294.2 U/l 28.42 63.55 automated serum analysis 0.0 0 105053 3010
Crl:SD serum total cholesterol level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood cholesterol amount male 63 days 5 89.4 mg/dl 3.33 7.44 automated serum analysis 0.0 0 105063 3010
Crl:SD plasma phosphate level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood phosphate amount female 91 days-154 days 0 6.17 mg/dl 0.32 automated plasma phosphate test 0 automated plasma phosphate analysis (MMO:0000795) plasma PO 110145 3067
Crl:SD liver campesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. liver campesterol amount not specified 77 days 2 0.03 mg/g unspecified method 0.0 0 tissue campesterol measurement test 70520 1300
Crl:SD plasma glucose level control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. blood glucose amount male 63 days-77 days 8 111.6 mg/dl 1.8 5.09 liquid phase colorimetry 0.0 0 C 75856 1540
Crl:SD number of podocytes per kidney glomerulus control condition Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 427 days 6 212.59 null 18.05 44.21 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 0 100793 2522
Crl:SD serum alanine aminotransferase activity level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood alanine transaminase amount male 63 days 5 54.8 U/l 0.97 2.17 automated serum analysis 0.0 0 105051 3010
Crl:SD serum glucose level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood glucose amount male 63 days 5 132.6 mg/dl 2.52 5.64 automated serum analysis 0.0 0 105065 3010
Crl:SD plasma albumin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood albumin amount female 91 days-154 days 0 28.2 g/l 1.3 automated plasma albumin analysis 0 plasma albumin level 106832 3067
Crl:SD plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait male 91 days-154 days 0 284.6 umol/g 0.33 osmometry 0.0 0 calculated plasma osmolality - mmol/kg body weight 111470 3067
Crl:SD plasma chloride level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood chloride amount female 91 days-154 days 0 101.6 mmol/l 0.67 automated plasma chloride test 0 plasma chloride 106872 3067
Crl:SD plasma alanine aminotransferase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood alanine transaminase amount female 91 days-154 days 0 41.0 U/l 4.32 automated plasma alanine aminotransferase activity assay 0 automated plasma alanine aminotransferase activity assay (MMO:0000808) plasma ALT 106880 3067
Crl:SD plasma calcium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood calcium amount male 91 days-154 days 0 2.38 mmol/l 0.02 automated plasma calcium test 0 automated plasma calcium test (MMO:0000804) plasma calcium 110148 3067
Crl:SD plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait female 91 days-154 days 0 284.8 umol/g 1.02 osmometry 0.0 0 calculated plasma osmolality - mmol/kg body weight 111471 3067
Crl:SD water drink intake rate control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. drinking behavior trait male 42 days 8 35.0 ml/d 0.7 1.98 unspecified method 0.0 0 C 75868 1540
Crl:SD serum creatinine level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood creatinine amount male 63 days 5 0.23 mg/dl 0.0 0.01 automated serum analysis 0.0 0 105061 3010
Crl:SD number of podocytes per kidney glomerulus control condition Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. podocyte morphology trait male 364 days 5 212.59 null 11.41 25.51 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 0 100779 2522
Crl:SD brain campesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. brain campesterol amount not specified 77 days 2 0.02 mg/g unspecified method 0.0 0 tissue campesterol measurement test 70528 1300
Crl:SD liver sitosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. liver sitosterol amount not specified 77 days 2 0.03 mg/g unspecified method 0.0 0 tissue lipid analysis 70537 1300
Crl:SD brain phytosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. brain phytosterol amount not specified 77 days 2 0.03 mg/g unspecified method 0.0 0 tissue lipid analysis 70554 1300
Crl:SD liver cholesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. liver cholesterol amount not specified 77 days 2 1.72 mg/g unspecified method 0.0 0 tissue total cholesterol analysis 70163 1300
Crl:SD plasma glucose level control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. blood glucose amount male 42 days 8 118.8 mg/dl 5.4 15.27 liquid phase colorimetry 0.0 0 C 75860 1540
Crl:SD water drink intake rate control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. drinking behavior trait male 63 days-77 days 8 43.0 ml/d 1.7 4.81 unspecified method 0.0 0 C 75864 1540
Crl:SD liver weight to body weight ratio control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. liver mass male 63 days 5 0.46 g/kg 0.01 0.03 post excision weight measurement 0.0 0 105045 3010
Crl:SD serum urea nitrogen level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood urea nitrogen amount male 63 days 5 12.4 mg/dl 0.25 0.55 automated serum analysis 0.0 0 105059 3010
Crl:SD plasma creatinine level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood creatinine amount female 91 days-154 days 0 0.2 mg/dl 0.0 automated plasma creatinine analysis 0 plasma creatinine 106868 3067
Crl:SD plasma alanine aminotransferase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood alanine transaminase amount male 91 days-154 days 0 51.16 U/l 5.41 automated plasma alanine aminotransferase activity assay 0 automated plasma alanine aminotransferase activity assay (MMO:0000808) plasma ALT 106879 3067
Crl:SD plasma urea nitrogen level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood urea nitrogen amount female 91 days-154 days 0 5.21 mmol/l 0.43 automated plasma urea analysis 0 plasma urea nitrogen 106840 3067
Crl:SD plasma potassium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood potassium amount female 91 days-154 days 0 3.74 mmol/l 0.08 automated plasma potassium test 0 plasma potassium 106856 3067
Crl:SD plasma creatinine level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood creatinine amount male 91 days-154 days 0 0.17 mg/dl 0.02 automated plasma creatinine analysis 0 plasma creatinine 106867 3067
Crl:SD plasma phosphate level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood phosphate amount male 91 days-154 days 0 7.33 mg/dl 0.28 automated plasma phosphate test 0 automated plasma phosphate analysis (MMO:0000795) plasma PO 110144 3067
Crl:SD plasma calcium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood calcium amount female 91 days-154 days 0 2.38 mmol/l 0.04 automated plasma calcium test 0.0 0 automated plasma calcium test (MMO:0000804) plasma calcium 110149 3067
Crl:SD liver phytosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. liver phytosterol amount not specified 77 days 2 0.05 mg/g unspecified method 0.0 0 tissue lipid analysis 70550 1300
Crl:SD plasma insulin level control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. blood insulin amount male 63 days-77 days 8 33.0 mU/l 2.0 5.66 radioimmunoassay 0.0 0 C 75848 1540
Crl:SD systolic blood pressure control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. arterial blood pressure trait male 63 days-77 days 8 141.0 mmHg 2.0 5.66 tail cuff plethysmography tail 0.0 0 C 75852 1540
Crl:SD food intake rate control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. eating behavior trait male 63 days-77 days 8 28.0 g/d 0.9 2.55 unspecified method 0.0 0 C 75872 1540
Crl:SD kidney glomerulus volume control condition Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. kidney glomerulus morphology trait male 427 days 6 2.36 x 10E6 um3 0.24 0.59 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 0 100788 2522
Crl:SD body weight control condition Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. body mass male 88 days-94 days 11 448.0 g 8.0 26.53 body weighing method 0.0 0 107351 3077
Crl:SD plasma globulin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood globulin amount female 91 days-154 days 0 31.8 g/l 0.4 automated plasma globulin analysis 0 automated plasma globulin analysis (MMO:0000806) plasma globulin 106836 3067
Crl:SD plasma urea nitrogen level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood urea nitrogen amount male 91 days-154 days 0 6.01 mmol/l 0.56 automated plasma urea analysis 0 plasma urea nitrogen 106839 3067
Crl:SD plasma total cholesterol level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood cholesterol amount male 91 days-154 days 0 66.8 mg/dl 8.49 automated plasma total cholesterol analysis 0 plasma total cholesterol 106847 3067
Crl:SD plasma glucose level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood glucose amount female 91 days-154 days 0 160.02 mg/dl 4.32 automated plasma glucose analysis 0 plasma glucose 106860 3067
Crl:SD plasma gamma-glutamyltransferase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood gamma-glutamyltransferase amount male 91 days-154 days 0 0.6 U/l 0.33 automated plasma gamma-glutamyltransferase activity assay 0.0 0 automated plasma gamma-glutamyltransferase activity assay (MMO:0000831) plasma GGT activity 106863 3067
Crl:SD plasma campesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. blood campesterol amount not specified 77 days 2 1.3 mg/dl unspecified method 0.0 0 plasma campesterol measurement test 70515 1300
Crl:SD brain cholesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. brain cholesterol amount not specified 77 days 2 10.95 mg/g unspecified method 0.0 0 tissue lipid analysis 70524 1300
Crl:SD serum total bilirubin level control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. blood bilirubin amount male 63 days 5 0.1 mg/dl 0.0 0.0 automated serum analysis 0.0 0 below lower limit 105055 3010
Crl:SD plasma sitosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. blood sitosterol amount not specified 77 days 2 1.95 mg/dl unspecified method 0.0 0 70532 1300
Crl:SD plasma total cholesterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. blood cholesterol amount not specified 77 days 2 54.6 mg/dl unspecified method 0.0 0 70158 1300
Crl:SD plasma phytosterol level control condition Yu H, et al., BMC Cardiovasc Disord 2003 Jun 3;3(1):4. blood phytosterol amount not specified 77 days 2 3.3 mg/dl unspecified method 0.0 0 70545 1300
Crl:SD food intake rate control condition Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7. eating behavior trait male 42 days 8 18.0 g/d 0.3 0.85 unspecified method 0.0 0 C 75876 1540
Crl:SD plasma total bilirubin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood bilirubin amount female 91 days-154 days 0 0.14 mg/dl 0.02 automated plasma total bilirubin analysis 0.0 0 automated plasma total bilirubin analysis (MMO:0000824) total plasma bilirubin 111467 3067
Crl:SD plasma chloride level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood chloride amount male 91 days-154 days 0 101.83 mmol/l 0.31 automated plasma chloride test 0 plasma chloride 106871 3067
Crl:SD plasma alkaline phosphatase activity level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood alkaline phosphatase amount female 91 days-154 days 0 160.4 IU/l 30.09 automated plasma alkaline phosphatase activity assay 0 plasma AP 106876 3067
Crl:SD plasma globulin level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood globulin amount male 91 days-154 days 0 31.16 g/l 0.54 automated plasma globulin analysis 0 automated plasma globulin analysis (MMO:0000806) plasma globulin 106835 3067
Crl:SD plasma triglyceride level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood triglyceride amount male 91 days-154 days 0 0.83 mmol/l 0.22 automated plasma triglyceride analysis 0 plasma triglyceride 106843 3067
Crl:SD plasma sodium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood sodium amount female 91 days-154 days 0 141.8 mmol/l 0.58 automated plasma sodium test 0 plasma sodium 106852 3067
Crl:SD plasma potassium level control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood potassium amount male 91 days-154 days 0 4.33 mmol/l 0.15 automated plasma potassium test 0 plasma potassium 106855 3067
Crl:SD both kidneys wet weight to body weight ratio control condition (for 63 days) Cheng Y, et al., Biopharm Drug Dispos. 2016 Jul;37(5):276-86. doi: 10.1002/bdd.2011. kidney mass male 63 days 5 0.1 g/kg 0.0 0.0 post excision weight measurement 0.0 0 105047 3010
Crl:SD kidney glomerulus volume control condition Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. kidney glomerulus morphology trait male 364 days 5 2.36 x 10E6 um3 0.16 0.36 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 0 100775 2522